ZA906957B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA906957B
ZA906957B ZA906957A ZA906957A ZA906957B ZA 906957 B ZA906957 B ZA 906957B ZA 906957 A ZA906957 A ZA 906957A ZA 906957 A ZA906957 A ZA 906957A ZA 906957 B ZA906957 B ZA 906957B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
therapie
thrombosis
prophylaxis
combination
Prior art date
Application number
ZA906957A
Other languages
English (en)
Inventor
Jutta Heim
Heim Jutta
Fredericus Alphonsu Asselbergs
Alphonsus Maria Ass Fredericus
Rolf Buergi
Buergi Rolf
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA906957B publication Critical patent/ZA906957B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA906957A 1989-09-01 1990-08-31 Pharmaceutical compositions ZA906957B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919803A GB8919803D0 (en) 1989-09-01 1989-09-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA906957B true ZA906957B (en) 1991-06-26

Family

ID=10662394

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906957A ZA906957B (en) 1989-09-01 1990-08-31 Pharmaceutical compositions

Country Status (17)

Country Link
US (1) US5409700A (xx)
EP (1) EP0421918B1 (xx)
JP (1) JP2904893B2 (xx)
KR (1) KR910005882A (xx)
AT (1) ATE94407T1 (xx)
AU (1) AU627927B2 (xx)
CA (1) CA2024309C (xx)
DD (1) DD299155A5 (xx)
DE (1) DE69003342T2 (xx)
DK (1) DK0421918T3 (xx)
ES (1) ES2058871T3 (xx)
GB (1) GB8919803D0 (xx)
IE (1) IE63523B1 (xx)
IL (1) IL95525A (xx)
NZ (1) NZ235107A (xx)
PT (1) PT95159B (xx)
ZA (1) ZA906957B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
WO2001032915A2 (en) 1999-11-04 2001-05-10 Genentech, Inc. Reversed-phase hplc assay for plasminogen activators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Also Published As

Publication number Publication date
NZ235107A (en) 1992-07-28
IE63523B1 (en) 1995-05-03
JP2904893B2 (ja) 1999-06-14
DE69003342D1 (de) 1993-10-21
DK0421918T3 (da) 1993-11-15
ATE94407T1 (de) 1993-10-15
IL95525A0 (en) 1991-06-30
DD299155A5 (de) 1992-04-02
GB8919803D0 (en) 1989-10-18
IL95525A (en) 1995-03-30
EP0421918A1 (en) 1991-04-10
CA2024309C (en) 2003-05-27
KR910005882A (ko) 1991-04-27
US5409700A (en) 1995-04-25
PT95159B (pt) 1997-08-29
JPH03130231A (ja) 1991-06-04
AU6205390A (en) 1991-03-07
ES2058871T3 (es) 1994-11-01
IE903179A1 (en) 1991-03-13
EP0421918B1 (en) 1993-09-15
DE69003342T2 (de) 1994-02-24
CA2024309A1 (en) 1991-03-02
PT95159A (pt) 1991-05-22
AU627927B2 (en) 1992-09-03

Similar Documents

Publication Publication Date Title
IL91706A0 (en) Pharmaceutical combination compositions comprising a plasminogen activator and hirudin
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL80659A0 (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
EP0386757A3 (en) Biodegradable poly (phosphate esters)
EP0332918A3 (en) Compositions containing a calcium antagonist and a lipid-lowering agent
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
HUT55797A (en) Process for producing compounds inhibitting the activity of proteases having retroviral effect and pharmaceutical compositions comprising same
IL80900A (en) Pharmaceutical composition containing fibrinolytic compounds and carbacyclin analogues for treatment of thrombosis
IL89662A0 (en) Pharmaceutical compositions comprising interferon-beta 1
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
ZA906957B (en) Pharmaceutical compositions
IL95863A0 (en) Anticoagulant peptides and compositions containing them
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
ZA886401B (en) Modified plasminogen activators
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
GR3023211T3 (en) Use of staphylokinase for the preparation of a pharmaceutical composition for treating arterial thrombosis
IL99512A0 (en) Calcium uptake inhibitors
GR3019685T3 (en) Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
IL103856A0 (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
IL93901A0 (en) Intranasal compositions for the administration of physo-stigmine and arecoline
HU904162D0 (en) Medical compositions for the releasing of coronary convulsion by potentionating nitratic effect and for the releasing of fibrin
GB8927771D0 (en) Compositions for treatment of eczema
IE901315L (en) Mocification of plasminogen activators